Seikagaku: Announcements of individual stocks related to personnel changes.
Seikagaku: Announcements of individual stocks regarding the scheduled submission date of securities reports.
Seikagaku: Announcements of individual stocks related to personnel changes.
Seikagaku: Independent Officer Notification Form
Seikagaku: Notice regarding acceptance of the SI-6603 approval application by the US FDA
Seikagaku: Notice regarding changes in officers
Seikagaku: Announcement of an academic conference presentation on SI-6603 by Ferring Pharmaceuticals
Biochemical Industry: Notice regarding organizational changes and personnel changes
Seikagaku: Notice regarding the postponement of the announcement of financial results for the 3rd quarter of the fiscal year ending March 31, 2024
Seikagaku: Notice of support for the Reiwa 6 Noto Peninsula Earthquake
Seikagaku: Notice regarding personnel changes
Seikagaku: Notice Concerning Pivotal Test Results for Anti-Adhesion Material SI-449
Seikagaku: Notice regarding personnel changes
Seikagaku: Notice regarding top-line results of the phase III clinical trial (additional trial) of the lumbar disc herniation remedy SI-6603 in the United States
Seikagaku: Independent Officer Notification Form
Seikagaku: Notice regarding changes in officers, etc.
Seikagaku: Notice regarding partial revisions to the Basic Internal Control Policy
Seikagaku: Articles of association 2023-03-02
Seikagaku: Notice on organizational change and personnel change
Seikagaku: Notice on the formulation of a new medium-term business plan (March 2023 to March 2026)
No Data